Intracerebroventricular 2-hydroxypropyl-γ-cyclodextrin alleviates hepatic manifestations without distributing to the liver in a murine model of Niemann-Pick disease type C.

MLA

Yamada, Yusei, et al. “Intracerebroventricular 2-Hydroxypropyl-γ-Cyclodextrin Alleviates Hepatic Manifestations without Distributing to the Liver in a Murine Model of Niemann-Pick Disease Type C.” Life Sciences, vol. 350, Aug. 2024, p. 122776. EBSCOhost, https://doi.org/10.1016/j.lfs.2024.122776.

APA

Yamada, Y., Ishitsuka, Y., Fukaura-Nishizawa, M., Kawata, T., Ishii, A., Shirakawa, A., Sakai, T., Tanaka, M., Kondo, Y., Takeo, T., Nakagata, N., Motoyama, K., Higashi, T., Arima, H., Seki, T., Kurauchi, Y., Katsuki, H., Higaki, K., Ikeda, R., … Irie, T. (2024). Intracerebroventricular 2-hydroxypropyl-γ-cyclodextrin alleviates hepatic manifestations without distributing to the liver in a murine model of Niemann-Pick disease type C. Life Sciences, 350, 122776. https://doi.org/10.1016/j.lfs.2024.122776

Chicago

Yamada, Yusei, Yoichi Ishitsuka, Madoka Fukaura-Nishizawa, Tatsuya Kawata, Akira Ishii, Aina Shirakawa, Taichi Sakai, et al. 2024. “Intracerebroventricular 2-Hydroxypropyl-γ-Cyclodextrin Alleviates Hepatic Manifestations without Distributing to the Liver in a Murine Model of Niemann-Pick Disease Type C.” Life Sciences 350 (August): 122776. doi:10.1016/j.lfs.2024.122776.